NCT02559414View on ClinicalTrials.gov

Antiplatelet Therapy in HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

February 28, 2017

Conditions
HIVCardiovascular DiseasesInflammation
Interventions
DRUG

Aspirin

DRUG

Clopidogrel

Trial Locations (2)

10016

Bellevue Hospital, New York

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02559414 - Antiplatelet Therapy in HIV | Biotech Hunter | Biotech Hunter